Novo Nordisk

Novo Nordisk
Global healthcare company focused on diabetes care, obesity, and rare blood disorders.
About
What does Novo Nordisk do?
Novo Nordisk is a leading global healthcare company with a long history of driving change to defeat serious chronic diseases. Their primary focus areas include diabetes care, obesity, and rare blood and endocrine disorders. They are committed to advancing the science and treatment of these conditions through research, development, and patient support.
What is Novo Nordisk's revenue?
StartupHub estimates Novo Nordisk's annual revenue at $2.5B (range $1.5B to $10.0B, 62% confidence), based on comparable companies in the sector.
Where is Novo Nordisk headquartered?
Novo Nordisk is headquartered in Bagsværd, Denmark.
When was Novo Nordisk founded?
Novo Nordisk was founded in 1923.
What industry does Novo Nordisk operate in?
Novo Nordisk operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Longevity.
How many employees does Novo Nordisk have?
Novo Nordisk has approximately 62380 people on record.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
“Novo Nordisk ist der neueste Kauf. Diabetiker wird es noch die nächsten 20 Jahre geben. Vorallem wenn man bedenkt, dass viele Nationen so wirtschaftlich wachsen könnten und damit der Wohlstand kommt, dass es zwangsläufig zu Fettleibigkeit f…”
View on Reddit“Når jeg åbner LinkedIn for tiden, er der endeløse opslag fra folk, der forlader Novo Nordisk. Er der nogen, der har en idé om, hvorfor det sker? Er situationen derinde blevet så dårlig nu, at folk selv siger op?”
View on Reddit“Novo-Nordisk is the second-largest pharmaceutical company in the diabetes/obesity market, behind competitor Eli Lilly. Its m”
View on Reddit“Novo Nordisk is currently managing a major legal challenge as thousands of patients have filed lawsuits against the company over its drugs Ozempic and Wegovy. While the company isn't facing one single $2 billion lawsuit, legal analysts esti…”
View on Reddit“Novo Nordisk sinks 15% after weight loss drug fails to match Eli Lilly's in trial. rip bagholders”
View on Reddit“RFK Jr: "Today, over 100 members of Congress support a bill to fund Ozempic with Medicare... Most of these members have taken money from the manufacturer of that product... Novo Nordisk... It's a Danish company, but the Danish government do…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
